Literature DB >> 33078881

Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID-19: a meta-analysis.

C S Kow1, S S Hasan2,3.   

Abstract

Entities:  

Year:  2020        PMID： 33078881     DOI： 10.1111/joim.13183

Source DB:  PubMed          Journal:  J Intern Med        ISSN： 0954-6820            Impact factor:   8.989


× No keyword cloud information.
  10 in total

1.  Proton Pump Inhibitor Use Is Not Strongly Associated With SARS-CoV-2 Related Outcomes: A Nationwide Study and Meta-analysis.

Authors:  Simone Bastrup Israelsen; Martin Thomsen Ernst; Andreas Lundh; Lene Fogt Lundbo; Håkon Sandholdt; Jesper Hallas; Thomas Benfield
Journal:  Clin Gastroenterol Hepatol       Date:  2021-05-11       Impact factor: 13.576

2.  An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19.

Authors:  Jan Homolak; Ivan Kodvanj; Vladimir Trkulja
Journal:  Clin Drug Investig       Date:  2021-02-19       Impact factor: 2.859

3.  Factors associated to potentially inappropriate prescribing in older patients according to STOPP/START criteria: MoPIM multicentre cohort study.

Authors:  Marisa Baré; Marina Lleal; Sara Ortonobes; Maria Queralt Gorgas; Daniel Sevilla-Sánchez; Nuria Carballo; Elisabet De Jaime; Susana Herranz
Journal:  BMC Geriatr       Date:  2022-01-11       Impact factor: 3.921

4.  Pattern of medication utilization in hospitalized patients with COVID-19 in three District Headquarters Hospitals in the Punjab province of Pakistan.

Authors:  Zia Ul Mustafa; Chia Siang Kow; Muhammad Salman; Mahpara Kanwal; Muhammad Bilal Riaz; Samina Parveen; Syed Shahzad Hasan
Journal:  Explor Res Clin Soc Pharm       Date:  2021-12-29

5.  The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based Study.

Authors:  Asher Shafrir; Ariel A Benson; Lior H Katz; Tiberiu Hershcovici; Menachem Bitan; Ora Paltiel; Ronit Calderon-Margalit; Rifaat Safadi; Michal Shauly-Aharonov
Journal:  Front Pharmacol       Date:  2022-02-04       Impact factor: 5.810

6.  Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis.

Authors:  Hong-Bae Kim; Jung-Ha Kim; Bethany J Wolf
Journal:  Eur J Clin Pharmacol       Date:  2021-11-24       Impact factor: 3.064

7.  What is the role of proton pump inhibitors consumption on the clinical presentation and severity of COVID-19 infection?

Authors:  M A Shokri; T Moghadam Fard; T Ramim; A Hejrati; L Hejrati; M Mokhtare
Journal:  Ann Pharm Fr       Date:  2022-08-29

8.  Impact of proton pump inhibitors on the in-hospital outcome of COVID-19 patients: a retrospective study.

Authors:  Haijuan Yao; Hongyu Li; Zhuang Ma; Yanyan Wu; Yufu Tang; Hao Meng; Hao Yu; Chengfei Peng; Yue Teng; Quanyu Zhang; Tianyi Zhu; Haitao Zhao; Guiyang Chu; Zhenhua Tong; Lu Liu; Hui Lu; Xingshun Qi
Journal:  Therap Adv Gastroenterol       Date:  2022-06-14       Impact factor: 4.802

Review 9.  The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome.

Authors:  Denise Battaglini; Chiara Robba; Andrea Fedele; Sebastian Trancǎ; Samir Giuseppe Sukkar; Vincenzo Di Pilato; Matteo Bassetti; Daniele Roberto Giacobbe; Antonio Vena; Nicolò Patroniti; Lorenzo Ball; Iole Brunetti; Antoni Torres Martí; Patricia Rieken Macedo Rocco; Paolo Pelosi
Journal:  Front Med (Lausanne)       Date:  2021-06-04

10.  Exploring Drugs and Vaccines Associated with Altered Risks and Severity of COVID-19: A UK Biobank Cohort Study of All ATC Level-4 Drug Categories Reveals Repositioning Opportunities.

Authors:  Yong Xiang; Kenneth Chi-Yin Wong; Hon-Cheong So
Journal:  Pharmaceutics       Date:  2021-09-18       Impact factor: 6.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.